Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

α-synuclein aggregation reduces nigral myocyte enhancer Factor-2D in idiopathic and experimental Parkinson's disease

1 Sept 2010

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Nerve injury and regeneration
Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 20816781
DOI: 10.1016/j.nbd.2010.08.022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

α-synuclein aggregation reduces nigral myocyte enhancer Factor-2D in idiopathic and experimental Parkinson's diseasePMID 20816781Read ↗

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerationsSemantic proximity Read ↗

The role of alpha-synuclein in Parkinson's disease: insights from animal models.Semantic proximity Read ↗

α-Synuclein in Parkinson's Disease: Pathogenic Function and Translation into Animal ModelsSemantic proximity Read ↗

Deregulation of α-synuclein in Parkinson’s disease: Insight from epigenetic structure and transcriptional regulation of SNCASemantic proximity Read ↗

α-Synuclein and Mitochondrial Dysfunction in Parkinson’s DiseaseSemantic proximity Read ↗

Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivoSemantic proximity Read ↗

The Central Theme of Parkinson’s Disease: α-SynucleinSemantic proximity Read ↗

Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.Semantic proximity Read ↗

α-Synuclein, Parkinson's disease, and Alzheimer's diseaseSemantic proximity Read ↗

Alpha-synuclein and neurodegenerative diseasesSemantic proximity Read ↗

Alpha-synuclein and Parkinson's disease.Semantic proximity Read ↗

α-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.